HAASER CHARLES B 4
4 · YIELD10 BIOSCIENCE, INC. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
HAASER CHARLES B
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-25+11,500→ 11,500 totalExercise: $16.49Exp: 2031-01-25→ Common Stock (11,500 underlying)
Footnotes (1)
- [F1]These options will vest and become exercisable in equal quarterly installments over 4 years from 1/25/2021, beginning on 4/25/2021 and ending on 1/25/2025.